Disclosures: Melissa Kaltenbach: Nothing to Disclose, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support, Therese Bittermann: Nothing to Disclose 2218 DIGITAL PHENOTYPE VARIES BY ALCOHOL USE HISTORY AND HEPATIC ENCEPHALOPATHY Jessica Mellinger 1 Tingting Liu 2 Haila Asefa 3 Patricia Bloom 4 Sal Giorgi 2 Brenda Curtis 5 , 1 University of Michigan Hospitals and Health Centers, 2 Technology and Translational Research Unit, National Institute on Drug Abuse, 3 University of Michigan Hospitals and Health Center, 4 University of Michigan, Michigan Medicine, 5 National Institutes of Health Background: Hepatic encephalopathy (HE) is responsible for substantial cirrhosis-related burden and may be detectable by digital phenotyping
Cautions applicable to other GLP-1 agonists apply to tirzepatide
Even though there arent explicit instructions about what to eat on GLP-1s, there are some foods that it might be a good idea to limit or avoid for various reasons
Together, these findings indicate that the NTS is not merely a passive relay of visceral information, but can actively influence both homeostatic and hedonic components of feeding
They are breakthrough treatments for weight management and managing blood glucose levels and may confer additional benefits in treating neurodegenerative diseases, liver disease, and more
